Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Life (Basel) · 2022 · PMC8954652 · PMID 35330140

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Additionally, highly significant differences between non-PH and PH cohorts were observed with respect to echocardiographically determined sPAP (33.43 ± 7.77 mmHg vs. 45.23 ± 14.55 mmHg) and CRP (3.10 ± 7.50 mg/L vs. 7.30 ± 18.10 mg/L). 3.3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.